FEEDBACK REGULATION OF NEUROGENESIS IN MAMMALS
哺乳动物神经发生的反馈调节
基本信息
- 批准号:7027673
- 负责人:
- 金额:$ 33.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-01-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:apoptosiscell differentiationcell growth regulationchemoreceptorsfollistatingene interactiongenetic screeninggenetically modified animalsimmunofluorescence techniquein situ hybridizationlaboratory mousenervous system regenerationneurogenesisolfactionspolymerase chain reactionprotein biosynthesisrespiratory epitheliumtissue /cell culturewestern blottings
项目摘要
DESCRIPTION (provided by applicant): Understanding the biology of neuron production is of fundamental importance if we are to understand the origins of, and develop therapies for, disabilities of the nervous system. Although much is known about the signals that stimulate neurogenesis in mammals, signals that cause neurogenesis to cease when the nervous system has attained its appropriate size remain poorly understood. Yet negative regulation of neurogenesis is likely to be important not only during development, but also later, when persistence of negative signals may inhibit neuron regeneration. The olfactory epithelium (OE) of the mouse is a unique model system for studying this negative regulation. Many aspects of neurogenesis characteristic of the rest of the nervous system only during embryonic development are recapitulated throughout life in the OE, where neurogenesis proceeds continuously. Moreover, OE neurogenesis is a regulated process that maintains the number of differentiated neurons (olfactory receptor neurons [ORNs]) at a particular level. Studies in vivo and in vitro suggest that a signal, produced by neuronal cells (progenitors and ORNs) within the OE, acts on progenitors to inhibit proliferation and generation of new ORNs. Preliminary experiments indicate that growth and differentiation factor 11 (GDF 11) has characteristics expected of this signal. This idea is supported by the patterns of expression of Gdf11 and its putative receptors; the effects of GDF 11 on cultured OE cells; and the phenotypes of induced mutations in Gdf11 and its inhibitor, follistatin (Fst). To test the hypothesis that GDF11 is a crucial negative regulator of neurogenesis in the OE, three specific aims will be pursued: (1) GDF1 l's action in regulating OE neurogenesis will be elucidated, using genetic and pharmacological approaches in vitro and in vivo; (2) the role of Fst in OE neurogenesis in vivo will be determined using genetic tests; and (3) models for how GDF11 and Fst work together (and potentially with other factors) to achieve feedback regulation of neurogenesis will be developed and tested. These studies will provide insights into the molecular mechanisms by which neuron number -- and therefore, ultimately, function -- are regulated during development and regeneration of the mammalian nervous system.
描述(由申请人提供):如果我们要了解神经系统的残疾的起源并发展疗法,那么了解神经元产生的生物学至关重要。尽管对刺激哺乳动物神经发生的信号知之甚少,但是当神经系统达到其适当的大小时会导致神经发生停止的信号仍然很差。然而,神经发生的负调节不仅在发育过程中也很重要,而且后来,当负信号的持续性可能抑制神经元再生时。小鼠的嗅觉上皮(OE)是研究这种负调控的独特模型系统。神经发生的许多方面仅在胚胎发育过程中仅概括了神经发育过程中神经发生的整个生命,而神经发生不断进行。此外,OE神经发生是一个受调节的过程,该过程维持特定水平的分化神经元(嗅觉受体神经元[ORNS])的数量。体内和体外的研究表明,OE内神经元细胞(祖细胞和ORN)产生的信号作用于祖细胞以抑制新ORN的增殖和产生。初步实验表明,生长和分化因子11(GDF 11)具有该信号的特征。 GDF11及其推定受体的表达模式支持了这个想法。 GDF 11对培养的OE细胞的影响;以及GDF11及其抑制剂Follistatin(FST)中诱导突变的表型。为了检验GDF11是OE中神经发生的至关重要的负调节剂的假设,将使用遗传学和药理方法在体外和体内使用遗传学和药理方法来阐明GDF1 L在调节OE神经发生方面的作用的三个具体目标; (2)将使用基因检测确定FST在体内OE神经发生中的作用; (3)将开发和测试GDF11和FST如何共同工作(可能与其他因素一起工作(可能与其他因素)进行反馈调节。这些研究将提供有关在哺乳动物神经系统的发育和再生过程中神经元数(最终,功能)的分子机制的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE LEIGHTON CALOF其他文献
ANNE LEIGHTON CALOF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE LEIGHTON CALOF', 18)}}的其他基金
Spatial Dynamics of Tissue and Organ Size Control
组织和器官大小控制的空间动力学
- 批准号:
9150331 - 财政年份:2015
- 资助金额:
$ 33.88万 - 项目类别:
Spatial Dynamics of Tissue and Organ Size Control
组织和器官大小控制的空间动力学
- 批准号:
9038609 - 财政年份:2015
- 资助金额:
$ 33.88万 - 项目类别:
Spatial Dynamics of Tissue and Organ Size Control
组织和器官大小控制的空间动力学
- 批准号:
9309099 - 财政年份:2015
- 资助金额:
$ 33.88万 - 项目类别:
Identify the strategies that tissues use to control growth
确定组织用于控制生长的策略
- 批准号:
8516154 - 财政年份:2007
- 资助金额:
$ 33.88万 - 项目类别:
NIPBL, Cohesin and Related Structural Birth Defects
NIPBL、粘连蛋白和相关结构性出生缺陷
- 批准号:
8079355 - 财政年份:2006
- 资助金额:
$ 33.88万 - 项目类别:
NIPBL, Cohesin and Related Structural Birth Defects
NIPBL、粘连蛋白和相关结构性出生缺陷
- 批准号:
8264763 - 财政年份:2006
- 资助金额:
$ 33.88万 - 项目类别:
相似国自然基金
α-MSH通过H3K4me3调控骨髓HSC分化为单核细胞促进炎性肠炎的机制研究
- 批准号:82302060
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
CD276驱动口腔癌代谢重编程及Treg细胞分化诱导免疫治疗抵抗的机制
- 批准号:82372811
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
组蛋白甲基转移酶KMT2C在前列腺癌细胞转分化和内分泌治疗耐受中的功能及机制研究
- 批准号:82372771
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Wnt通路探讨装载淫羊藿次苷II外泌体靶向骨髓间充质干细胞成骨分化抗骨质疏松治疗的机制研究
- 批准号:82374164
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
- 批准号:
10634881 - 财政年份:2023
- 资助金额:
$ 33.88万 - 项目类别:
Neuroendocrine differentiation post anti-androgenic therapy: Role of Tribbles 2
抗雄激素治疗后的神经内分泌分化:Tribbles 2 的作用
- 批准号:
10659525 - 财政年份:2023
- 资助金额:
$ 33.88万 - 项目类别:
TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
骨骼肌萎缩中的 TWEAK/Fn14/UPR 信号转导
- 批准号:
10660397 - 财政年份:2023
- 资助金额:
$ 33.88万 - 项目类别:
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
重新设计黑色素瘤微环境中铁死亡的差异调节
- 批准号:
10735217 - 财政年份:2023
- 资助金额:
$ 33.88万 - 项目类别:
The role of Septin6 Group in Murine and Human Hematopoiesis
Septin6 组在小鼠和人类造血中的作用
- 批准号:
10718515 - 财政年份:2023
- 资助金额:
$ 33.88万 - 项目类别: